Centogene N : Voting Proxy Centogene AGM June 2023
June 05, 2023
Share
VOTING PROXY
THE UNDERSIGNED
Name :
Address :
acting on behalf of (only to be completed if relevant)
Name :
Address :
(the "Principal").
DECLARES AS FOLLOWS
The Principal hereby registers for the annual general meeting of shareholders of Centogene N.V. (the "Company") to be held on June 30, 2023 at 2.00 p.m. CEST at the offices of NautaDutilh N.V., Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands (the "AGM") and, for purposes of being represented at the AGM, grants a power of attorney to Mr. P.C.S. van der Bijl, civil law notary and partner of NautaDutilh N.V., or any substitute to be appointed by him (the "Proxyholder").
The scope of this power of attorney extends to the performance of the following acts on behalf of the Principal at the AGM:
to exercise the voting rights of the Principal in accordance with paragraph 3 below; and
to exercise any other right of the Principal which the Principal would be allowed to exercise at the AGM.
This power of attorney shall be used by the Proxyholder to exercise the Principal's voting rights in the manner directed as set out below. If no choice is specified in respect of the sole voting item on the agenda, the Proxyholder shall vote "FOR" such agenda item.
Agenda item
FOR
AGAINST
ABSTAIN
Extension of the period for drawing up the Dutch statutory
annual accounts and board report for the financial year
ended December 31, 2022
Instruction to Ernst & Young Accountants LLP for the
external audit of the Company's annual accounts for the
financial year ended December 31, 2022
Instruction to Ernst & Young Accountants LLP for the
external audit of the Company's annual accounts for the
financial year ending December 31, 2023
Appointment of Prof. Dr. Peter Andreas Bauer as
82043617 M 52659159 / 1
managing director of the Company
Appointment of Mary Blake Sheahan as supervisory director of the Company
Reappointment of Peer Michael Schatz as supervisory director of the Company
Extension of authorization for the Company's management board (the "Management Board") to issue shares and grant rights to subscribe for shares
Extension of authorization for the Management Board to limit and exclude pre-emption rights
Extension of authorization for the Management Board to acquire shares and depository receipts for shares in the Company's capital
This power of attorney is granted with full power of substitution.
The relationship between the Principal and the Proxyholder under this power of attorney is governed exclusively by the laws of the Netherlands.
(signature page follows)
82043617 M 52659159 / 1
SIGN HERE
Please return this signed proxy via regular mail or e-mail to:
If the Principal is a beneficial owner of shares in the Company's capital, please carefully review the convening
notice for the AGM and enclose the relevant documents stipulated by such convening notice.
82043617 M 52659159 / 1
Attachments
Original Link
Original Document
Permalink
Disclaimer
Centogene NV published this content on 06 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 June 2023 08:03:05 UTC.
Centogene N.V., is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
CENTOGENE N.V. 
